TY - JOUR
T1 - Safety and efficacy of index admission cholecystectomy in severity-stratified acute cholangitis hospitalizations
AU - Jaan, Ali
AU - Najim, Mostafa Suhail
AU - Maryyum, Adeena
AU - Muhammad, Qurat Ul Ain
AU - Zahid, Effa
AU - Farooq, Umer
AU - Dhawan, Ashish
AU - Javed, Haseeba
AU - Cryer, Byron
AU - Ahlawat, Sushil
N1 - Publisher Copyright:
© 2025
PY - 2025/9/1
Y1 - 2025/9/1
N2 - Introduction: Cholecystectomy (CCY) is generally advocated for patients presenting with acute cholangitis (AC) to ensure definitive management and prevent recurrence. The optimal timing for cholecystectomy (CCY), however, remains to be determined. This study aims to comprehend the clinical outcomes and financial implications of performing a CCY during index admission. Methods: We conducted a retrospective cohort study using data from the Nationwide Readmission Database (2016–2020). Adult patients admitted with a diagnosis of AC were categorized based on whether CCY was performed during index admission and were further stratified by severity per the Tokyo Guidelines. Mortality, resource utilization, and readmission rates were analyzed using a multivariate Cox regression model. STATA 14.2 was utilized for statistical analysis. Results: Of 29,241 adult patients with AC, 4319 (14.77 %) underwent CCY during the index admission. Patients with index admission CCY had lower comorbidity index and AC severity compared to those without index admission CCY (P < 0.01). Significantly lower in-hospital mortality (adjusted hazard ratio (aHR) 0.40, P < 0.01), 30-day and 90-day readmission rates (aHR 0.49 and 0.48 respectively, P < 0.01) were observed for the index CCY group. Reduced mortality and improved readmission rates were persistent on subgroup analysis for severe and non-severe cholangitis patients. Conclusion: Our findings advocate the effectiveness of index admission CCY in lowering mortality and readmission rates, irrespective of AC severity. These findings highlight the need for future prospective studies and updated guidelines on surgical intervention in AC management.
AB - Introduction: Cholecystectomy (CCY) is generally advocated for patients presenting with acute cholangitis (AC) to ensure definitive management and prevent recurrence. The optimal timing for cholecystectomy (CCY), however, remains to be determined. This study aims to comprehend the clinical outcomes and financial implications of performing a CCY during index admission. Methods: We conducted a retrospective cohort study using data from the Nationwide Readmission Database (2016–2020). Adult patients admitted with a diagnosis of AC were categorized based on whether CCY was performed during index admission and were further stratified by severity per the Tokyo Guidelines. Mortality, resource utilization, and readmission rates were analyzed using a multivariate Cox regression model. STATA 14.2 was utilized for statistical analysis. Results: Of 29,241 adult patients with AC, 4319 (14.77 %) underwent CCY during the index admission. Patients with index admission CCY had lower comorbidity index and AC severity compared to those without index admission CCY (P < 0.01). Significantly lower in-hospital mortality (adjusted hazard ratio (aHR) 0.40, P < 0.01), 30-day and 90-day readmission rates (aHR 0.49 and 0.48 respectively, P < 0.01) were observed for the index CCY group. Reduced mortality and improved readmission rates were persistent on subgroup analysis for severe and non-severe cholangitis patients. Conclusion: Our findings advocate the effectiveness of index admission CCY in lowering mortality and readmission rates, irrespective of AC severity. These findings highlight the need for future prospective studies and updated guidelines on surgical intervention in AC management.
UR - https://www.scopus.com/pages/publications/105015158007
UR - https://www.scopus.com/inward/citedby.url?scp=105015158007&partnerID=8YFLogxK
U2 - 10.1016/j.clinre.2025.102676
DO - 10.1016/j.clinre.2025.102676
M3 - Article
C2 - 40876512
AN - SCOPUS:105015158007
SN - 2210-7401
VL - 49
JO - Clinics and Research in Hepatology and Gastroenterology
JF - Clinics and Research in Hepatology and Gastroenterology
IS - 8
M1 - 102676
ER -